Avalglucosidase alfa
Avalglucosidase alfa
Avalglucosidase alfa (pronunciation: av-al-gloo-KOH-si-dase AL-fa) is a enzyme replacement therapy used for the treatment of Pompe disease, a rare genetic disorder.
Etymology
The name "Avalglucosidase alfa" is derived from the enzyme it replaces, alpha-glucosidase. "Aval" is a prefix used in pharmaceutical naming to denote a modified version of a naturally occurring substance, in this case, the enzyme alpha-glucosidase. "Alfa" is a common suffix used in pharmaceutical naming to denote a product of recombinant DNA technology.
Usage
Avalglucosidase alfa is used to treat Pompe disease, a rare genetic disorder characterized by muscle weakness and respiratory problems. It works by replacing the enzyme alpha-glucosidase, which is deficient in people with Pompe disease.
Related Terms
- Enzyme replacement therapy: A treatment method that involves replacing a missing or deficient enzyme in the body.
- Pompe disease: A rare genetic disorder characterized by muscle weakness and respiratory problems.
- Alpha-glucosidase: An enzyme that breaks down glycogen, a form of sugar stored in the body's cells.
See Also
External links
- Medical encyclopedia article on Avalglucosidase alfa
- Wikipedia's article - Avalglucosidase alfa
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski